[The primary study on a novel protein binding to the death domain of the death receptor 4]

Xiao-ling Li1, Yan-xin Liu, Shi-lian Liu

  • 1National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, PUMC and CAMS, Beijing 100005, China.

Abstract

Insights

Researchers identified human formyl peptide receptor-like 1 (FPRL1) as a novel protein that binds to the death receptor 4 (DR4) cytoplasmic domain. This interaction may play a role in apoptosis signaling pathways.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Immunology

Context:

  • Death receptor 4 (DR4) is a key mediator of apoptosis.
  • Understanding DR4-interacting proteins is crucial for deciphering cell death pathways.
  • Novel protein interactions with DR4 remain to be fully elucidated.

Purpose:

  • To clone and identify novel proteins that bind to the death domain of DR4.
  • To investigate the specific interaction between identified proteins and the DR4 cytoplasmic domain (DR4CD).

Summary:

  • A yeast two-hybrid system identified two positive clones, pADB1 and pADB2.
  • Sequence analysis revealed pADB1 insert homology to human formyl peptide receptor-like 1 (FPRL1) mRNA (97%).
  • Co-immunoprecipitation confirmed specific in vivo binding of FPRL1 to DR4CD.

Impact:

  • Identified FPRL1 as a potential binding partner for DR4.
  • Suggests a novel role for FPRL1 in DR4-mediated signaling.
  • Provides a foundation for further functional studies of FPRL1 in TNF-related apoptosis-inducing ligand (TRAIL) pathways.

Related Concept Videos